Newsday spoke with health experts about the difference between influenza and norovirus, both at high levels in the United ...

Norovirus is the country's leading cause of vomiting, diarrhea, and foodborne illness, and right on schedule, it's picking up ...

Though evacuations related to norovirus are not common, travel insurance policies with Emergency Medical Evacuation coverage can pay for transportation to another medical facility if a physician deems ...

Alcohol-based hand sanitizers are ineffective against the norovirus. Hand-washing is the best way to prevent it.

Given the vomiting and diarrhea, the biggest risk with norovirus is dehydration, which can turn a short-term illness into a ...

Subject enrollment expected to begin in Q1 2026 CDI-988 is the first oral broad-spectrum antiviral drug candidate for potential prevention of norovirus outbreaks and treatment of acute viral ...

NEWARK, N.J. (PIX11) — A highly contagious virus that spread rapidly across the tri-state area last winter could make a resurgence. Data collected at the Passaic Valley Sewerage Commission in Newark ...

Outbreaks of a highly contagious stomach bug dubbed “winter vomiting disease” are surging across the U.S. From Aug. 1 through Nov. 13, 153 outbreaks of norovirus were reported in 14 states, according ...

It’s the holiday guest no one invited. The notorious “winter vomiting disease” is spreading rapidly across the country, with cases of the potentially deadly virus doubling over the past few months as ...

Norovirus treatment exerts a significant burden on Veterans Health Administration (VHA) spending, totalling $28 million in costs when extrapolated annually. That is according to an October study ...

There are currently no approved vaccines or treatments for norovirus infection Cocrystal’s CDI-988 is the first antiviral for the potential prevention and treatment of viral gastroenteritis caused by ...

Cocrystal Pharma, Inc. announced that its investigational antiviral drug CDI-988 has shown strong efficacy against the newly dominant norovirus variants GII.17 and previously prevalent GII.4, amid a ...